Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments (CLIA), and Patient Protection and Affordable Care Act; Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency
medicare · Centers for Medicare and Medicaid Services · Rule · Published 2020-09-02 · Effective 2020-09-02 · 85 FR 54820
Document
Document number
2020-19150
Federal Register citation
85 FR 54820
CFR reference
42 CFR 410
Type
Rule
Action
Interim final rule with comment period.
Category
medicare
Sub-agency
Centers for Medicare and Medicaid Services
Publication date
2020-09-02
Effective date
2020-09-02
HHS docket
CMS-3401-IFC
Abstract
This interim final rule with comment period (IFC) revises regulations to strengthen CMS' ability to enforce compliance with Medicare and Medicaid long-term care (LTC) facility requirements for reporting information related to coronavirus disease 2019 (COVID-19), establishes a new requirement for LTC facilities for COVID-19 testing of facility residents and staff, establishes new requirements in the hospital and critical access hospital (CAH) Conditions of Participation (CoPs) for tracking the incidence and impact of COVID-19 to assist public health officials in detecting outbreaks and saving lives, and establishes requirements for all CLIA laboratories to report COVID-19 test results to the Secretary of Health and Human Services (Secretary) in such form and manner, and at such timing and frequency, as the Secretary may prescribe during the Public Health Emergency (PHE).